Molecular mechanisms of intrahepatic metastasis of hepatocellular carcinoma and application for diagnosis and treatment

肝细胞癌肝内转移的分子机制及其在诊疗中的应用

基本信息

  • 批准号:
    12470049
  • 负责人:
  • 金额:
    $ 3.65万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Intrahepatic metastasis is one of the most important prognostic factors for patients with hepatocellular carcinoma (HCC). Cell motility mediated by Rho-and p160 Rho-associated coiled-coil forming protein kinase (p160ROCK) signaling pathways has recently been shown to play a critical role in intrahepatic metastasis in human HCC. One of such highly metastatic cell line, KYN-2 cells having a high level of c-Src kinase activity become scattered, extend lamellipodia, and exhibit high motility in adherent condition. Expression of a dominant-negative mutant form of c-Src caused formation of stress fibers and focal adhesions, and markedly reduced motility. it was suggested that c-Src activation is critically involved in carcinoma cell migration and metastasis. To investigate whether the specific p160ROCK inhibitor Y-27632 could also inhibit intrahepatic metastasis, the effect of Y-27632 on the cell motility and intrahepatic metastasis of Li7 was investigated. Y-27632 markedly blocked actin reo … More rganization and motility of Li7 cells mediated by lysophosphatidic acid. Y-27632 was administered continuously into the peritoneal cavity using a micro-osmotic pump, together with orthotopic implantation of Li7 cells into the liver of SCID mice. The incidence of mice with metastatic nodules decreased in the Y-27632-treated group. These findings confirm the importance of the Rho/p160ROCK signaling pathway in intrahepatic metastasis of human HCC, and indicate that Y-27632 may be useful for the prevention of intrahepatic metastasis of human HCC.Crucial genes involved in liver cancer metastasis were screened using differential display analysis. A novel gene, DRH1, which is frequently down-regulated in HCC was identified. CO-029 was found to be frequently and significantly overexpressed in HCC and in tumors with intrahepatic spreading. In contrast, mRNA expression of the other tetraspanins CD9 and CD82 was down-regulated in HCC, especially in tumors with intrahepatic spreading. It was suggested that CO-029 has some roles in the promotion of metastasis of HCC. Less
肝内转移是影响肝癌患者预后的重要因素之一。最近研究表明,由Rho和p160 Rho相关卷曲螺旋形成蛋白激酶(p160 ROCK)信号通路介导的细胞运动在人肝癌肝内转移中起关键作用。这种高转移性细胞系之一,具有高水平c-Src激酶活性的KYN-2细胞变得分散,延伸板状伪足,并在贴壁条件下表现出高运动性。显性负突变形式的c-Src的表达引起应力纤维和局灶性粘连的形成,并显着降低运动性。提示c-Src活化与癌细胞迁移和转移密切相关。为了研究特异性p160 ROCK抑制剂Y-27632是否也可以抑制肝内转移,研究了Y-27632对Li 7细胞运动性和肝内转移的影响。Y-27632显著阻断肌动蛋白还原酶, ...更多信息 溶血磷脂酸介导的Li 7细胞的组织化和运动。使用微渗透泵将Y-27632连续施用到腹膜腔中,同时将Li 7细胞原位植入到SCID小鼠的肝脏中。在Y-27632治疗组中,具有转移性结节的小鼠的发生率降低。这些结果证实了Rho/p160 ROCK信号通路在人肝癌肝内转移中的重要性,提示Y-27632可能对人肝癌肝内转移有一定的预防作用。一个新的基因,DRH 1,这是经常下调肝癌被确定。发现CO-029在HCC和具有肝内扩散的肿瘤中频繁且显著地过表达。相反,其他四跨膜蛋白CD 9和CD 82的mRNA表达在HCC中下调,特别是在肝内扩散的肿瘤中。提示CO-029在促进肝癌转移中有一定作用。少

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kanetaka K., Sakamoto M., et al.: "Involvement of c-Src in carcinoma cell motility and metastasis."Jpn. J. Cancer Res.. 92(9). 941-946 (2001)
Kanetaka K.、Sakamoto M. 等:“c-Src 在癌细胞运动和转移中的参与”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takamura,M.,Sakamoto,M.,Genda,T.,Ichida,T.,Asakura,H.,Hirohashi,S.: "Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632."Hepatology. (In press). (2001)
Takamura,M.、Sakamoto,M.、Genda,T.、Ichida,T.、Asakura,H.、Hirohashi,S.:“Rho 相关蛋白激酶抑制剂 Y-27632 抑制人肝细胞癌肝内转移。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kengo Kanetaka, Michiie Sakamoto, Yoshiya Yamamoto, Susumu Yamasaki, Francois Lanza, Takashi Kanematsu, Setsuo Hirohashi: "Overexpression of tetraspanin CO-029 in hepatocellular carcinoma"J. Hepatol.. 35. 637-642 (2001)
Kengo Kanetaka、Michiie Sakamoto、Yoshiya Yamamoto、Susumu Yamasaki、Francois Lanza、Takashi Kanematsu、Setsuo Hirohashi:“肝细胞癌中四跨膜蛋白 CO-029 的过度表达”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamamoto Y., Sakamoto., et al.: "Cloning and characterization of a novel gene, DRHJ, down-regulated in advanced human hepatocellular carcinoma."Clin. Cancer Res.. 7(2). 297-303 (2001)
Yamamoto Y.、Sakamoto. 等人:“新基因 DRHJ 的克隆和表征,该基因在晚期人类肝细胞癌中下调。”Clin。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Genda,T.,Sakamoto,M.,Ichida,M.,Asakura,H.,Hirohashi,S.: "Loss of cell-cell contact is induced by integrin-mediated cell-substratum adhesion in highly-motile and highly-metastatic hepatocellular carcinoma cells."Lab Invest.. 80(3). 387-394 (2000)
Genda,T.、Sakamoto,M.、Ichida,M.、Asakura,H.、Hirohashi,S.:“在高活动性和高转移性中,整合素介导的细胞与基质粘附会导致细胞与细胞接触的丧失。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAKAMOTO Michiie其他文献

SAKAMOTO Michiie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAKAMOTO Michiie', 18)}}的其他基金

Establishing the molecular pathology-based subclassification of hepatocellular carcinoma.
建立基于分子病理学的肝细胞癌亚分类。
  • 批准号:
    26293081
  • 财政年份:
    2014
  • 资助金额:
    $ 3.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Expression and functional analyses of G protein-coupled receptor GPR49/LGR5 in human tissues and diseases
G蛋白偶联受体GPR49/LGR5在人体组织和疾病中的表达及功能分析
  • 批准号:
    21390108
  • 财政年份:
    2009
  • 资助金额:
    $ 3.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of individualized diagnosis for cancer of digestive organ
消化器官肿瘤个体化诊断进展
  • 批准号:
    17015042
  • 财政年份:
    2005
  • 资助金额:
    $ 3.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Molecular mechanisms of progression and metastasis of hepatocellular carcinoma and their application on diagnosis and therapy.
肝细胞癌进展和转移的分子机制及其在诊断和治疗中的应用。
  • 批准号:
    15390118
  • 财政年份:
    2003
  • 资助金额:
    $ 3.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

The role and interrelationship of PRDM1 and p53 in the regulation of differentiation, invasion, and metastasis of hepatocellular carcinoma
PRDM1和p53在肝细胞癌分化、侵袭和转移调控中的作用及相互关系
  • 批准号:
    23K15048
  • 财政年份:
    2023
  • 资助金额:
    $ 3.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The role of regulation and subcellular localization of GTP biosynthesis in melanoma invasion and metastasis
GTP生物合成的调控和亚细胞定位在黑色素瘤侵袭和转移中的作用
  • 批准号:
    10636058
  • 财政年份:
    2023
  • 资助金额:
    $ 3.65万
  • 项目类别:
Deciphering epigenetically-regulated pathways to improve targeted therapy for invasion and metastasis in head and neck cancer
破译表观遗传调控途径以改善头颈癌侵袭和转移的靶向治疗
  • 批准号:
    10650527
  • 财政年份:
    2023
  • 资助金额:
    $ 3.65万
  • 项目类别:
The role of MIRO2 in tumor cell invasion and metastasis
MIRO2在肿瘤细胞侵袭和转移中的作用
  • 批准号:
    10704512
  • 财政年份:
    2022
  • 资助金额:
    $ 3.65万
  • 项目类别:
The role of FMNL2 in invasion and metastasis
FMNL2在侵袭和转移中的作用
  • 批准号:
    462700
  • 财政年份:
    2022
  • 资助金额:
    $ 3.65万
  • 项目类别:
    Operating Grants
The role of MIRO2 in tumor cell invasion and metastasis
MIRO2在肿瘤细胞侵袭和转移中的作用
  • 批准号:
    10464387
  • 财政年份:
    2022
  • 资助金额:
    $ 3.65万
  • 项目类别:
Development of a glioblastoma treatment based on CLIC2, a protein that inhibits invasion and metastasis of malignant tumors
基于CLIC2(一种抑制恶性肿瘤侵袭和转移的蛋白质)开发胶质母细胞瘤治疗方法
  • 批准号:
    21K16611
  • 财政年份:
    2021
  • 资助金额:
    $ 3.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Crosstalk between Netrin-1 and BMP regulates the invasion and metastasis of melanoma
Netrin-1与BMP的串扰调控黑色素瘤的侵袭和转移
  • 批准号:
    21K10260
  • 财政年份:
    2021
  • 资助金额:
    $ 3.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting radiation driven invasion and metastasis in cancers of unmet need
针对未满足需求的癌症中的辐射驱动的侵袭和转移
  • 批准号:
    MR/T04358X/1
  • 财政年份:
    2021
  • 资助金额:
    $ 3.65万
  • 项目类别:
    Fellowship
Effects of fibroblast inhibitor on invasion and metastasis of oral cancer
成纤维细胞抑制剂对口腔癌侵袭和转移的影响
  • 批准号:
    21K10039
  • 财政年份:
    2021
  • 资助金额:
    $ 3.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了